Ambria Capital

Healing Maps is a mental health platform established in 2020 and headquartered in Miami, Florida. The company focuses on providing education and information regarding psychedelic-assisted therapies, particularly those involving ketamine. It offers a variety of resources, including in-depth articles on medical psychedelics and a directory to locate nearby clinics. By delivering accurate and transparent information about psychedelic treatments, Healing Maps aims to empower individuals to understand their options and access the appropriate care for their mental wellness needs.

Tyson 2.0 is a cannabis company founded by the renowned boxer and entrepreneur Mike Tyson. The company specializes in producing a diverse range of cannabis products, including full-spectrum cannabis flowers, concentrates, and consumables. With a commitment to purity and precision, Tyson 2.0 aims to provide consumers with high-quality products that are both premium and affordable. These offerings are widely accessible at retailers across the nation, ensuring that a broad audience can enjoy their products.

Wonder Sciences operates a comprehensive ecosystem focused on mental health and wellness. It includes Wondermed, which collaborates with physicians to offer innovative psychedelic and somatic therapies for holistic healing. Wonder Clinics serve as mental health centers that provide psychedelic-assisted therapies alongside traditional medicine and advanced neuroscience techniques. Additionally, Wonder Research is dedicated to advancing clinical research through scientific studies aimed at establishing evidence-based protocols for psychedelic treatments. The company also features an online telemedicine platform that facilitates access to these therapies, allowing patients dealing with depression and anxiety to engage in safe, self-healing journeys from home.

Semasio GmbH, founded in 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to provide a platform that helps marketers build detailed user profiles and identify target groups. Semasio's offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, utilizing Natural Language Processing to analyze website content and create comprehensive profiles for both websites and users. This enables clients, including global agency networks and advertisers, to strategically address specific audiences and optimize their advertising efforts. Additionally, Semasio's technology allows for precise control over the contextual placements of online advertising content, ensuring relevance and efficiency. With development centers in Denmark and Portugal, Semasio is dedicated to enhancing the effectiveness of programmatic advertising in a privacy-conscious environment.

MycroDose Therapeutics is a U.S.-based pharmaceutical company focused on developing advanced drug delivery systems that utilize psychedelic compounds for the treatment of mental health disorders and cognitive degenerative diseases. The company is actively working on two of its four core technologies, which include a psilocybin transdermal delivery system and a ketamine oral mucosa delivery system. By leveraging these innovative approaches, MycroDose Therapeutics aims to enhance the efficacy and accessibility of treatments for patients dealing with these challenging conditions.

NanoPsy is a company that develops nanotechnology for theranostic applications to effectively improve psychedelic drug efficacy. Our patented nano technology which, in combination with our targeted delivery and controlled dosing technology methods, will allow for an increase in solubility/absorption of these molecules. Thus a more efficacious API.

WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine. The company was founded in 2020 by Daniel Carcillo and is headquartered in Homer Glen, Illinois, United States.

WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine. The company was founded in 2020 by Daniel Carcillo and is headquartered in Homer Glen, Illinois, United States.